Detalles de la búsqueda
1.
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.
Blood
; 111(11): 5350-8, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18292288
2.
Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.
J Clin Oncol
; 27(26): 4357-64, 2009 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19652067
Resultados
1 -
2
de 2
1
Próxima >
>>